Onconova Therapeutics Reports Full Year 2020 Financial Results, Provides Business Update
11 mars 2021 16h05 HE
|
Onconova Therapeutics, Inc.
Conference call begins at 4:30 p.m. Eastern time today NEWTOWN, Pa., March 11, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a clinical-stage biopharmaceutical...
Onconova Therapeutics to Provide Corporate Update and Full Year 2020 Financial Results
04 mars 2021 16h15 HE
|
Onconova Therapeutics, Inc.
Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time on Thursday, March 11, 2021 NEWTOWN, Pa., March 04, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a...
Onconova Therapeutics to Participate in Three Investment Conferences During the Month of March
01 mars 2021 08h00 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, PA., March 01, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products for...
Onconova Therapeutics Regains Compliance with Nasdaq Continued Listing Requirement
24 févr. 2021 08h00 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products for patients...
Onconova Therapeutics, Inc. Announces Closing of $28.75 Million Public Offering of Common Stock Including Full Exercise of the Over-Allotment Option
16 févr. 2021 16h03 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics to Present Corporate Update at the 2021 BIO CEO & Investor Digital Conference
16 févr. 2021 08h00 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products for patients...
Onconova Therapeutics, Inc. Announces Pricing of $25 Million Public Offering of Common Stock
10 févr. 2021 22h49 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
10 févr. 2021 16h01 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat...
Onconova Therapeutics, Inc. to Present at NobleCon17 Virtual Event
14 janv. 2021 08h00 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products for patients...
Onconova Therapeutics, Inc. Announces $8.7 Million Public Offering
07 janv. 2021 09h40 HE
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX) (“Onconova”), a biopharmaceutical company focused on discovering and developing novel products to treat...